I agree that this site is using cookies. You can find further informations here.
X
Laquer, Vivian
50  results:
Search for persons X
?
1

493 - Lebrikizumab does not impact vaccine-induced immune r..:

Soung, Jennifer ; Laquer, Vivian ; Merola, Joseph F...
British Journal of Dermatology.  190 (2024)  Supplement_2 - p. ii3-ii3 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Importance of treating acne sequelae in skin of color: 6‐mo..:

Alexis, Andrew ; Del Rosso, James Q. ; Forman, Seth...
International Journal of Dermatology.  63 (2024)  6 - p. 806-815 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Safety of Lebrikizumab in Adults and Adolescents with Moder..:

Stein Gold, Linda ; Thaçi, Diamant ; Thyssen, Jacob P....
American Journal of Clinical Dermatology.  24 (2023)  4 - p. 595-607 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Safety and Efficacy of Lebrikizumab in Adolescent Patients ..:

Paller, Amy S. ; Flohr, Carsten ; Eichenfield, Lawrence F....
Dermatology and Therapy.  13 (2023)  7 - p. 1517-1534 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Botulinum Toxin for the Lower Face:

, In: Manual of Botulinum Toxin Therapy,
Pérez-Atamoros, Francisco ; Hernández, Carolina ; Laquer, Vivian. - p. 197-206 , 2023
Link: https://doi.org/10.1017/..
 
?
6

Efficacy and safety of switching from dupilumab to upadacit..:

Blauvelt, Andrew ; Ladizinski, Barry ; Prajapati, Vimal H....
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. 478-485 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Lebrikizumab Delivers Clinically Meaningful and Continuous ..:

Yosipovitch, Gil ; Zeidler, Claudia ; Apfelbacher, Christian J....
SKIN The Journal of Cutaneous Medicine.  7 (2023)  6 - p. s273 , 2023
Link: https://doi.org/10.25251..
 
?
8

42917 Safety and efficacy of lebrikizumab in adolescent pat..:

Paller, Amy ; Flohr, Carsten ; Eichenfield, Lawrence F....
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB84 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Long-term 2-year safety and efficacy of tralokinumab in adu..:

Blauvelt, Andrew ; Langley, Richard G. ; Lacour, Jean-Philippe...
Journal of the American Academy of Dermatology.  87 (2022)  4 - p. 815-824 , 2022
Link: https://doi.org/10.1016/..
 
?
10

A phase 3 open-label, randomized multicenter study to evalu..:

Magnolo, Nina ; Kingo, Külli ; Laquer, Vivian...
Journal of the American Academy of Dermatology.  86 (2022)  1 - p. 122-130 , 2022
Link: https://doi.org/10.1016/..
 
?
11

33047 Simultaneous improvements in skin signs and quality o..:

Browning, John ; Laquer, Vivian ; Magnolo, Nina
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB109 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Efficacy of Secukinumab Across Subgroups and Overall Safety..:

Magnolo, Nina ; Kingo, Külli ; Laquer, Vivian...
Pediatric Drugs.  24 (2022)  4 - p. 377-387 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Interleukin-33 antibody failed to demonstrate benefit in a ..:

Laquer, Vivian ; Parra, Viviana ; Lacour, Jean-Philippe...
British Journal of Dermatology.  187 (2022)  4 - p. 599-602 , 2022
Link: https://doi.org/10.1111/..
 
?
14

33317 Study of nemolizumab pharmacokinetics, safety, and ef..:

Sidbury, Robert ; Alpizar, Sady ; Laquer, Vivian
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB114 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Halobetasol propionate lotion 0.05% in patients 12 to 16 ye..:

Laquer, Vivian ; Nguyen, Andrea ; Squittieri, Nicholas.
JAAD International.  6 (2022)  - p. 13-19 , 2022
Link: https://doi.org/10.1016/..
 
1-15